Literature DB >> 17235626

Assessment and data analysis of health-related quality of life in clinical trials for gastric cancer treatments.

Satoshi Morita1, Adrian A Kaptein, Akira Tsuburaya, Yasuhiro Kodera, Takanori Matsui, Junichi Sakamoto.   

Abstract

This review contains a practical guide as well as a number of design and analytical methods for conducting health-related quality of life assessments in clinical trials for gastric cancer treatment. Although we address issues specific to the assessment of gastric cancer, many are applicable to clinical trials for different cancer types.

Entities:  

Mesh：

Year:  2006        PMID： 17235626     DOI： 10.1007/s10120-006-0400-9

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN： 1436-3291            Impact factor:   7.370


  44 in total

1.  Beyond the development of quality-of-life instruments: where do we go from here?

Authors:  Mark N Levine; Patricia A Ganz
Journal:  J Clin Oncol       Date:  2002-05-01       Impact factor: 44.544

Review 2.  Quality of life in patients with advanced colorectal cancer: what has been learnt?

Authors:  T Conroy; H Bleiberg; B Glimelius
Journal:  Eur J Cancer       Date:  2003-02       Impact factor: 9.162

Review 3.  Quality-of-life assessment in cancer treatment protocols: research issues in protocol development.

Authors:  C C Gotay; E L Korn; M S McCabe; T D Moore; B D Cheson
Journal:  J Natl Cancer Inst       Date:  1992-04-15       Impact factor: 13.506

4.  A cross-validation of the European Organization for Research and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30) for Japanese with lung cancer.

Authors:  K Kobayashi; F Takeda; S Teramukai; I Gotoh; H Sakai; S Yoneda; Y Noguchi; H Ogasawara; K Yoshida
Journal:  Eur J Cancer       Date:  1998-05       Impact factor: 9.162

5.  Assessment of quality of life in clinical trials of the British Medical Research Council.

Authors:  D Machin
Journal:  J Natl Cancer Inst Monogr       Date:  1996

6.  A modular approach to quality-of-life assessment in cancer clinical trials.

Authors:  N K Aaronson; M Bullinger; S Ahmedzai
Journal:  Recent Results Cancer Res       Date:  1988

Review 7.  Quality of life in gastric cancer.

Authors:  Ad-A Kaptein; Satoshi Morita; Junichi Sakamoto
Journal:  World J Gastroenterol       Date:  2005-06-07       Impact factor: 5.742

8.  Random-effects models for longitudinal data.

Authors:  N M Laird; J H Ware
Journal:  Biometrics       Date:  1982-12       Impact factor: 2.571

9.  Assessing clinical benefit in the treatment of pancreas cancer: gemcitabine compared to 5-fluorouracil.

Authors:  H Burris; A M Storniolo
Journal:  Eur J Cancer       Date:  1997-01       Impact factor: 9.162

Review 10.  Applications of multiple imputation in medical studies: from AIDS to NHANES.

Authors:  J Barnard; X L Meng
Journal:  Stat Methods Med Res       Date:  1999-03       Impact factor: 3.021
View more
  3 in total

1.  Validity of the Japanese version of functional assessment of cancer therapy-gastric (FACT-Ga) and its sensitivity to ascites volume change: a retrospective analysis of Japanese clinical trial participants.

Authors:  Hiromichi Maeda; Maho Sato; Michiya Kobayashi; Nobuhiro Takiguchi; Takaki Yoshikawa; Shigefumi Yoshino; Kazuhiro Yoshida; Akira Tsuburaya; Junichi Sakamoto; Satoshi Morita
Journal:  Support Care Cancer       Date:  2016-06-07       Impact factor: 3.603

2.  Systematic collection of patient reported outcome research data: A checklist for clinical research professionals.

Authors:  Leslie Wehrlen; Mike Krumlauf; Elizabeth Ness; Damiana Maloof; Margaret Bevans
Journal:  Contemp Clin Trials       Date:  2016-03-19       Impact factor: 2.226

3.  Health utility of patients with advanced gastrointestinal stromal tumors (GIST) after failure of imatinib and sunitinib: findings from GRID, a randomized, double-blind, placebo-controlled phase III study of regorafenib versus placebo.

Authors:  Chris D Poole; Mark P Connolly; Jane Chang; Craig J Currie
Journal:  Gastric Cancer       Date:  2014-06-24       Impact factor: 7.370
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.